Medherant Limited

Medherant Limited company information, Employees & Contact Information

Medherant is a clinical-stage company developing innovative treatments using its novel transdermal drug delivery technology, the TEPI Patch, which is based on a proprietary adhesive developed by its scientists. The Company was founded by Professor David Haddleton and the University of Warwick in 2015 based on their world-leading expertise in bioadhesives and polymer chemistry. The adhesive has a high drug loading capacity, so a smaller quantity of adhesive is needed to deliver a therapeutic dose; the patch can therefore be thinner and more flexible. It also enables excipients, such as permeation enhancers, to be included in the adhesive so the release of the drug from the patch can be tailored to achieve the desired product profile. The adhesive also provides excellent adhesion, even in moist conditions. This means that the patch remains in contact with the skin throughout the dosing period, so the full dose is delivered. There is no leakage of adhesive from the patch so there is no unsightly black ring around its edge and no residue on the skin after removal. Medherant undertakes feasibility studies for other companies to investigate whether their drugs can be formulated for transdermal delivery using the TEPI technology. Medherant welcomes enquires from companies interested in licensing its products for commercialisation or undertaking feasibility studies.

Company Details

Employees
17
Founded
-
Address
Coventry
Phone
442476323060
Email
in****@****t.co.uk
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
London.
HQ
Coventry
Looking for a particular Medherant Limited employee's phone or email?

Medherant Limited Questions

News

Innovative patch technology for transdermal drug delivery - Nature

Innovative patch technology for transdermal drug delivery Nature

Medherant - Pharmaceutical Technology

Medherant Pharmaceutical Technology

Medherant: Game-changing drug delivery technology - Health Tech World

Medherant: Game-changing drug delivery technology Health Tech World

[Withdrawn] Medherant: pioneering drug delivery through the skin - GOV.UK

[Withdrawn] Medherant: pioneering drug delivery through the skin GOV.UK

SCRA Spinout Case Study - Medherant - University of Warwick

SCRA Spinout Case Study - Medherant University of Warwick

Researchers working on world’s only testosterone patch for menopause - The Independent

Researchers working on world’s only testosterone patch for menopause The Independent

Menopause testosterone patch to begin trials - BBC

Menopause testosterone patch to begin trials BBC

Pharmaceutical expert Ken Cunningham appointed as chair to Medherrant - mercia.co.uk

Pharmaceutical expert Ken Cunningham appointed as chair to Medherrant mercia.co.uk

Warwick graduate invents revolutionary device for testing drugs - University of Warwick

Warwick graduate invents revolutionary device for testing drugs University of Warwick

Innovative testosterone treatment for post-menopausal women - University of Warwick

Innovative testosterone treatment for post-menopausal women University of Warwick

Top Medherant Limited Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant